OpenAlex
PricingAboutJobs
Log inGet started
Work

The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand.

PubMed

Year: 2004
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: Mark Shackleton, Ian D Davis, Wendie Hopkins, Heather Jackson, Nektaria Dimopoulos, Tsin Tai, Qiyuan Chen, Phillip Parente, Michael Jefford, Kelly-Anne Masterman, Dania Caron, Weisan Chen, Eugene Maraskovsky, Jonathan Cebon
Institutions: Ludwig Cancer Research, Austin Health
Language: English

Topic: Immunotherapy and Immune Responses
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: imiquimod, Flt3 ligand, melanoma, peptide vaccination, TLR7, dendritic cell maturation, CD8+ T cells, skin immune response, hematologic toxicity, monocytosis, metastatic melanoma, NY-ESO-1, Melan-A, tyrosinase
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2129619903
FWCI: 3.681
Cites: 47
Cited by: 131
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms